Tandem Diabetes Care TNDM reported its Q4 earnings results on Wednesday, February 21, 2024 at 04:05 PM.
Here's what investors need to know about the announcement.
Earnings
Tandem Diabetes Care missed estimated earnings by 8.0%, reporting an EPS of $-0.27 versus an estimate of $-0.25.
Revenue was down $23.71 million from the same period last year.
Past Earnings Performance
Last quarter the company missed on EPS by $0.04 which was followed by a 14.37% drop in the share price the next day.
Here's a look at Tandem Diabetes Care's past performance:
| Quarter | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 |
|---|---|---|---|---|
| EPS Estimate | -0.34 | -0.53 | -0.52 | -0.06 |
| EPS Actual | -0.38 | -0.30 | -0.63 | -0.01 |
| Revenue Estimate | 192.34M | 197.64M | 170.23M | 221.83M |
| Revenue Actual | 185.62M | 195.92M | 169.38M | 220.50M |
To track all earnings releases for Tandem Diabetes Care visit their earnings calendar here.
This article was generated by Benzinga's automated content engine and reviewed by an editor.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Date | ticker | name | Actual EPS | EPS Surprise | Actual Rev | Rev Surprise |
|---|
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
